摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-4-bromo-2-hydroxy-butyric acid ethyl ester | 1201687-17-3

中文名称
——
中文别名
——
英文名称
(R)-4-bromo-2-hydroxy-butyric acid ethyl ester
英文别名
ethyl(2R)-4-bromo-2-hydroxybutanoate;ethyl (2R)-4-bromo-2-hydroxybutanoate
(R)-4-bromo-2-hydroxy-butyric acid ethyl ester化学式
CAS
1201687-17-3
化学式
C6H11BrO3
mdl
——
分子量
211.056
InChiKey
OOFYYUYDYBKRGY-RXMQYKEDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    10
  • 可旋转键数:
    5
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.83
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

点击查看最新优质反应信息

文献信息

  • Compounds 148
    申请人:AstraZeneca AB
    公开号:US08119673B2
    公开(公告)日:2012-02-21
    This invention relates to novel pharmaceutically useful compounds of formula (I), in particular compounds that are competitive inhibitors of trypsin-like serine proteases, especially thrombin, their use as medicaments, pharmaceutical compositions containing them and synthetic routes to their production.
    本发明涉及一种新型的具有药用价值的化合物,其化学式为(I),特别是一种竞争性抑制剂,可抑制胰蛋白酶丝氨酸蛋白酶,特别是凝血酶,其作为药物的用途,包含它们的制药组合物和合成路线。
  • Heterocyclic Carboxamides For Use As Thrombin Inhibitors
    申请人:Branalt Jonas
    公开号:US20110130432A1
    公开(公告)日:2011-06-02
    This invention relates to novel pharmaceutically useful compounds of formula (I), in particular compounds that are competitive inhibitors of trypsin-like serine proteases, especially thrombin, their use as medicaments, pharmaceutical compositions containing them and synthetic routes to their production. Formula (I)
    该发明涉及一种新型的具有药用价值的化合物(I) ,特别是一种具有竞争性的胰蛋白酶丝氨酸蛋白酶抑制剂的化合物,尤其是血栓素,其用作药物,包含它们的制药组合物以及制造它们的合成路线。化学式(I)。
  • NEW HETEROCYCLIC CARBOXAMIDES FOR USE AS THROMBIN INHIBITORS
    申请人:AstraZeneca AB
    公开号:EP2321301A1
    公开(公告)日:2011-05-18
  • US8119673B2
    申请人:——
    公开号:US8119673B2
    公开(公告)日:2012-02-21
  • [EN] NEW HETEROCYCLIC CARBOXAMIDES FOR USE AS THROMBIN INHIBITORS<br/>[FR] NOUVEAUX CARBOXAMIDES HÉTÉROCYCLIQUES UTILISÉS COMME INHIBITEURS DE THROMBINE
    申请人:ASTRAZENECA AB
    公开号:WO2009157860A1
    公开(公告)日:2009-12-30
    This invention relates to novel pharmaceutically useful compounds of formula (I), in particular compounds that are competitive inhibitors of trypsin-like serine proteases, especially thrombin, their use as medicaments, pharmaceutical compositions containing them and synthetic routes to their production. Formula (I)
查看更多